Steven T. Rosen, MD

Provost & Chief Scientific Officer
Toni Stephenson Lymphoma Center, Beckman Research Institute,City of Hope

Poster(s):

• 1404 - A Phase 2 study with Tafasitamab and Zanubrutinib in newly diagnosed chronic lymphocytic leukemia/small lymphocytic lymphoma – TaZa CLL Study

• 1605 - Phase 2 study of the combination of lisocabtagene maraleucel, nivolumab, and ibrutinib in Richter’s transformation - NCT05672173

• 1607 - MGA Loss drives cristae remodeling and redox adaptation via MICOS and PRDX2 in Richters transformation

• 1717 - MVA-based GEO-CM04S1 vaccine results in improved cellular immune response in patients with chronic lymphocytic leukemia (CLL) compared with mRNA-based vaccine: initial results of a Phase II randomized study